Back

Bio Protocol Secures $6.9 Million Seed Funding Led by Maelstrom Fund

Bio Protocol's latest funding round, led by Maelstrom Fund and Animoca Brands, reflects a growing interest in decentralized science (DeSci) and AI-driven biotech research.

Summary

Bio Protocol, a decentralized science (DeSci) platform, raised $6.9 million in a seed funding round led by Maelstrom Fund and Animoca Brands. The platform aims to revolutionize drug discovery by integrating AI, blockchain, and community-driven approaches. With AI-native biotech research and decentralized governance, Bio Protocol is positioning itself as a leader in the DeSci movement, addressing inefficiencies in traditional scientific research funding and methodology.

Terms & Concepts
  • DeSci: A movement leveraging blockchain and decentralized technologies to advance scientific research, collaboration, and funding beyond traditional institutional control.
  • AI-native biotech research: Biotech research that is primarily driven by artificial intelligence technologies, aiming to accelerate and streamline the drug discovery process.
  • BioAgents: Decentralized AI agents used by Bio Protocol to generate hypotheses and connect researchers to onchain wallets for funding and experiments.